Cleveland Clinic FoundationCleveland, OH
Disclosures:
1065 - Use of the 40-Gene Expression Profile (40-GEP) Test to Identify Immune Suppressed Patients with Brigham and Womens Hospital (BWH) T1-T2a Cutaneous Squamous Cell Carcinoma (cSCC) at Higher Risk of Meta
Tuesday, October 1, 20243:00 PM – 3:05 PM ET